| 000 | 00778cam a2200253 4500 | ||
|---|---|---|---|
| 020 | _a1899040056 | ||
| 035 | _a(Sirsi) a55043 | ||
| 060 | _aQV 771 97GU | ||
| 245 | 0 | 0 |
_aGuidelines for the economic evaluation of pharmaceuticals : _bcan the UK learn from Australia and Canada? / _cedited by Adrian Towse. |
| 260 |
_aLondon : _bOffice of Health Economics, _c1997. |
||
| 300 | _a70 p. | ||
| 596 | _a4 | ||
| 650 | 0 | 2 | _aDrug evaluation. |
| 650 | 0 | 2 | _aDrug costs. |
| 650 | 0 | 2 | _aCost-benefit analysis. |
| 650 | 0 | 2 | _aGuidelines. |
| 651 | 2 | _aUnited Kingdom. | |
| 651 | 2 | _aAustralia. | |
| 651 | 2 | _aCanada. | |
| 700 | _aTowse, Adrian. | ||
| 710 | 2 | _aOffice of Health Economics (London), England. | |
| 008 | s1997 gb 1 0 eng | ||
| 942 |
_2NLM _cMONOGRAPH |
||
| 999 |
_c18680 _d18680 |
||